Jenna A Moran
Overview
Explore the profile of Jenna A Moran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amrein P, Preffer F, Fell G, Attar E, Narayan R, Blonquist T, et al.
Leuk Lymphoma
. 2025 Mar;
:1-11.
PMID: 40070233
Outcome for acute myeloid leukemia (AML) patients aged >60 years is poor. Targeting the proteasome in AML is attractive, since leukemia stem cells demonstrate sensitivity to proteasome inhibition in preclinical...
2.
Narayan R, Blonquist T, Emadi A, Hasserjian R, Burke M, Lescinskas C, et al.
Cancer
. 2019 Dec;
126(6):1264-1273.
PMID: 31860140
Background: Outcomes for patients with relapsed/refractory acute myeloid leukemia (R/R AML) remain poor. Novel therapies specifically targeting AML are of high interest. Brentuximab vedotin (BV) is an antibody-drug conjugate that...
3.
Brunner A, Blonquist T, DeAngelo D, McMasters M, Fell G, Hermance N, et al.
Lancet Haematol
. 2019 Dec;
7(2):e122-e133.
PMID: 31837959
Background: Increased aurora A kinase (AAK) expression occurs in acute myeloid leukaemia; AAK inhibition is a promising therapeutic target in this disease. We therefore aimed to assess the activity of...
4.
Fathi A, Blonquist T, Hernandez D, Amrein P, Ballen K, McMasters M, et al.
Cancer
. 2017 Sep;
124(2):306-314.
PMID: 28960265
Background: Cabozantinib, a tyrosine kinase inhibitor of FMS-like tyrosine kinase 3 (FLT3), MET, AXL, vascular endothelial growth factor receptor, and KIT, is approved for use in multiple malignancies. We assessed...
5.
Jalbut M, Sohani A, Dal Cin P, Hasserjian R, Moran J, Brunner A, et al.
Leuk Res Rep
. 2015 May;
4(1):28-30.
PMID: 25973391
Klinefelter syndrome (KS), a 47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to date. We present...